The table below shows Avidity Biosciences, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$18.75M
$10.90M
$9.56M
$9.22M
$9.33M
$6.79M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$559.16M
$303.59M
$190.97M
$150.40M
$101.18M
$37.60M
SG&A
$205.54M
RNA annual revenue (10-K history)
Avidity Biosciences, Inc. reported annual revenue of $18.75M for fiscal year 2025. That is up 72.1% from $10.90M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $379.00K (FY 2018) to $18.75M. Figures come from the company's audited annual reports as filed with the SEC.
